Pdia1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Disulfide Isomerase (PDI) | |
|---|---|
| Protein Name | Protein Disulfide Isomerase (PDI) |
| Gene | PDIA1 |
| UniProt ID | P07237 |
| PDB ID(s) | 3UQW, 4EL1, 5E84 |
| Molecular Weight | ~57 kDa |
| Subcellular Location | Endoplasmic Reticulum Lumen |
| Protein Family | Protein Disulfide Isomerase Family |
Protein Disulfide Isomerase (PDI), encoded by the PDIA1 gene (also known as P4HB), is the founding member of the protein disulfide isomerase family. As one of the most abundant chaperone proteins in the endoplasmic reticulum (ER), PDI plays a central role in protein folding and cellular proteostasis. The enzyme catalyzes the formation, rearrangement, and reduction of disulfide bonds—a critical post-translational modification that stabilizes the three-dimensional structure of secretory and membrane proteins.
PDI is a 508-amino acid ER-resident protein that belongs to the thioredoxin superfamily. The protein possesses a characteristic multi-domain architecture consisting of:
This modular structure enables PDI to simultaneously recognize diverse substrate proteins while catalyzing disulfide bond formation through its dual active sites.
PDI undergoes cyclic oxidation and reduction during its catalytic cycle:
The three-dimensional structure of PDI has been resolved by X-ray crystallography and cryo-EM, revealing:
Crystal structures (PDB: 3UQW, 4EL1, 5E84) show the domain organization and have informed drug discovery efforts targeting PDI.
PDI exhibits multiple enzymatic activities essential for protein folding:
PDI participates in multiple aspects of ER quality control:
PDI interacts with numerous client proteins and partner proteins:
In Alzheimer's disease (AD), PDI is implicated through its role in ER stress response:
PDI involvement in Parkinson's disease (PD) centers on alpha-synuclein handling:
PDI plays roles in:
PDI represents a promising therapeutic target for neurodegenerative diseases:
Protein disulfide isomerase family A member 1 (PDIA1). UniProtKB P07237.
Protein disulfide isomerase: a promising therapeutic target for neurodegenerative diseases. Trends in Pharmacological Sciences. 2023;44(11):679-692. DOI:10.1016/j.tips.2023.06.002
The role of protein disulfide isomerase in Alzheimer's disease. Journal of Molecular Neuroscience. 2022;72(2):223-238. DOI:10.1007/s12031-021-01871-1
PDI protects neurons from ER stress-induced apoptosis. Cell Death & Differentiation. 2009;16(5):757-769. DOI:10.1038/cdd.2009.7
Upregulation of PDIA1 in Parkinson's disease brain. Neurobiology of Aging. 2014;35(11):e9-e17. DOI:10.1016/j.neurobiolaging.2014.06.025
Atkinson IC, et al. "Protein disulfide isomerase: a potential target for novel therapeutics." J Neurochem. 2021;159(2):354-373. DOI:10.1111/jnc.15356
Honjo Y, et al. "Protein disulfide isomerase accumulates in Lewy bodies." Acta Neuropathol. 2010;120(4):481-489. DOI:10.1007/s00401-010-0701-2
Uehara T, et al. "S-nitrosylated protein disulfide isomerase in neurodegeneration." Nat Neurosci. 2006;9(12):1508-1513. DOI:10.1038/nn1807